Product Recalls in North Dakota

Product recalls affecting North Dakota — including food, drugs, consumer products, medical devices, and vehicles distributed to North Dakota. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,535 recalls have been distributed to North Dakota in the last 12 months.

47,938 total recalls
2,535 in last 12 months

Showing 91819200 of 47,938 recalls

DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Levofloxacin Oral Solution Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Dicyclomine Hydrochloride Injection USP Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Diuril (chlorothiazide sodium) Injection Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Fentanyl Citrate Injection Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Prednisolone Oral Solution Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Valproic Acid Oral Solution Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Tobramycin Inhalation Solution USP Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Tobramycin Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Guaifenesin Oral Solution Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Apraclonidine Ophthalmic Solution 0.5% Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Acetaminophen & Codeine Phosphate Oral Solution 120mg/12mg/5mL Recalled by...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Lidocaine Hydrochloride Oral Topical Solution Recalled by Akorn, Inc. Due to...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Lidocaine HCl Jelly USP Recalled by Akorn, Inc. Due to CGMP Deviations: Firm...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Levetiracetam Oral Solution 100 mg/mL (100 mg/mL) Recalled by Akorn, Inc....

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Sodium Chloride Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Olopatadine HCl Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Cetrorelix Acetate for Injection Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: HydrALAZINE HCl Injection Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Guaiatussin AC Sugar-Free Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Hydrocortisone and Acetic Acid Otic Solution Recalled by Akorn, Inc. Due to...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund